Literature DB >> 1439022

From the archives of the AFIP. Leiomyosarcoma of the retroperitoneum and inferior vena cava: radiologic-pathologic correlation.

D S Hartman1, W S Hayes, P L Choyke, G P Tibbetts.   

Abstract

Leiomyosarcoma is the second most common primary retroperitoneal tumor in adults. Retroperitoneal leiomyosarcoma exhibits three major growth patterns: (a) completely extravascular (extraluminal) (62% of cases), (b) completely intravascular (intraluminal) (5% of cases), and (c) extra- and intraluminal (33% of cases). The usual clinical manifestation is a large abdominal mass. Intraluminal leiomyosarcoma may be accompanied by symptoms referable to venous thrombosis. The variable gross features and potential for intravascular extension result in various radiologic appearances, the most common being a large, partially necrotic soft-tissue mass in the retroperitoneum with or without extension into the inferior vena cava. Computed tomography and magnetic resonance imaging typically show a nonfatty, necrotic retroperitoneal mass and a vascular component when it is present. Ultrasound and angiography may also be useful, especially if vascular involvement is suspected from other imaging studies. Treatment of choice is surgical excision, which is frequently impossible due to the invasiveness of the tumor. Prognosis is related to extent of invasion and the adequacy of resection. Long-term prognosis is poor, and most patients die of local recurrence or distant metastasis.

Entities:  

Mesh:

Year:  1992        PMID: 1439022     DOI: 10.1148/radiographics.12.6.1439022

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  30 in total

1.  Right upper quadrant swelling due to leiomyosarcoma.

Authors:  Satish Gunwant; Chandra Shekhar Biyani; David Almond
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

2.  Malignant fibrous histiocytoma of the inferior vena cava: appearances on contrast-enhanced spiral CT and MRI.

Authors:  N L Kelekis; R C Semelka; M L Hill; D C Meyers; P L Molina
Journal:  Abdom Imaging       Date:  1996 Sep-Oct

3.  Local recurrence and multi-organ metastasis of primary retroperitoneal leiomyosarcoma in unusual locations after surgical resection.

Authors:  Hira Lal; Zafar Neyaz; Vinay Kumar Kapoor; Biju Pottakkat; Pallav Gupta
Journal:  J Radiol Case Rep       Date:  2011-06-01

4.  Metastatic leiomyosarcoma to the pancreas presenting as a massive upper gastrointestinal hemorrhage.

Authors:  Christian Andrade; Jon Finan; Prasad Kulkarni
Journal:  J Gastrointest Cancer       Date:  2014-12

5.  Leiomyosarcoma of the Inferior Vena Cava - Radical Resection, Vascular Reconstruction and Challenges: A Case Report and Review of Relevant Literature.

Authors:  Saptarshi Biswas; Arpit Amin; Suhaib Chaudry; Saju Joseph
Journal:  World J Oncol       Date:  2013-05-06

6.  Leiomyosarcoma of the Right Ovarian Vein: a Case Report with Multimodality Management and Long-Term Follow-Up.

Authors:  Virendra Rajpurohit; Pooja Mehta; Nirupama Kothari; Sanjay Nathani
Journal:  Indian J Surg Oncol       Date:  2019-05-31

7.  [Rare differential diagnosis on suspected liver tumor].

Authors:  B Kinkel; G Walgenbach-Brünagel; J H Risse; D O Pauleit
Journal:  Internist (Berl)       Date:  2009-05       Impact factor: 0.743

8.  Preoperative diagnosis by three-dimensional angiography of a leiomyosarcoma arising from the left ovarian vein.

Authors:  Susumu Saigusa; Masaki Ohi; Yasuhiro Inoue; Masato Kusunoki
Journal:  BMJ Case Rep       Date:  2013-04-16

9.  Primary leiomyosarcoma of the juxtarenal inferior vena cava: a case report.

Authors:  Surjeet Kumar; Anil Kumar; Sandeep Guleria
Journal:  Indian J Surg       Date:  2012-07-12       Impact factor: 0.656

Review 10.  Soft-Tissue Sarcomas of the Abdomen and Pelvis: Radiologic-Pathologic Features, Part 1-Common Sarcomas: From the Radiologic Pathology Archives.

Authors:  Angela D Levy; Maria A Manning; Waddah B Al-Refaie; Markku M Miettinen
Journal:  Radiographics       Date:  2017 Mar-Apr       Impact factor: 5.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.